Influence of Platelet Activation on Erythrocyte Deformability

Summary

Erythrocyte deformability was demonstrated to be influenced by platelet activation. Deformability of erythrocytes suspended in autologous platelet poor plasma (PPP), obtained from platelet rich plasma (PRP), was significantly reduced when PRP had previously been incubated with a platelet activating substance (arachidonic acid, adrenaline or ADP). The possibility of a direct influence of the activating substance on erythrocyte deformability was examined and malondialdehyde formation was determined as an indicator of platelet activation. Erythrocyte deformability was not impaired when endoperoxide formation in platelets was blocked by an inhibitor of cyclooxigenase (acetylsalicylic acid). Plasma viscosity was not influenced by platelet activation as demonstrated by filtration and viscosimetry. Recent studies showed that prostacyclin (PGI₂) increases erythrocyte deformability (1). The antagonistic action between prostacyclin released by vessel walls and products of platelet metabolism being well known, we discuss possible mechanisms of this effect and pathophysiological relevance of our results.

Keywords

Heparin - Prostacyclin - Platelet aggregation

• References

• 1 Neri-Semeri GG. Pathophysiological aspects of platelet aggregation in relation to blood flow rheology in microcirculation. Ric Clin Lab 1981; 11 suppl (Suppl. 01) 39-46
• 2 Schmid-Schonbein H. Blood rheology and physiology of microcirculation. Ric Clin Lab 1981; 11 suppl (Suppl. 01) 13-33
• 3 Editorial. Red cell deformability. Lancet 1978; 2: 1347-1352
• 4 Fischer TM, Stöhr-Liesen M, Schmid-Schönbein H. Red cells as fluid droplets; tank-tread like motion of human erythrocyte membrane in shear flow. Science 1978; 202: 894-896
• 5 Gaehtgens P, Schmid-Schönbein H, Schmidt F, Will G, Stöhr-Liesen M. Comparative microrheology of nucleated avian (NRBC) and non nucleated human (HRBC) erythrocytes during viscosimetry and small tube flow. Abstract – Second World Congress for Microcirculation; La Jolla (Calif.): 1977
• 6 Gross GP, Hathaway WE. Fetal erythrocyte deformability. Pediatr Res 1972; 6: 593-599
• 7 Weed RI. The importance of erythrocyte deformability. Am J Med 1970; 49: 147-150
• 8 Murphy JR. The influence of p^H and temperature on some physical properties of normal erythrocytes and erythrocytes from patients with hereditary sphaerocytosis. J Lab Clin Med 1967; 69: 758-775
• 9 Schmid-Schonbein H, Volger E. Red cell aggregation and cell deformability in diabetes. Diabetes 1976; 25 (Suppl. 02) 897-899
• 10 Barnes AJ, Locke P, Scudder PR, Dormandy TL, Dormandy AJ, Slack J. Is hyperviscosity a treatable component of diabetic microcir-culatory disease?. Lancet 1977; 2: 781-791
• 11 Gryglewski RJ, Bunting S, Moncada S, Flower JR, Vane JR. Arterial walls are protected against deposition of platelet thrombi by a substance (prostaglandin X) which they make from prostaglandin endoperoxides. Prostaglandins 1976; 12: 685-688
• 12 Reid HL, Barnes AJ, Lock PJ, Dormandy JA, Dormandy TL. A simple method for measuring erythrocyte deformability. J Clin Pathol 1976; 29: 855-858
• 13 Smith JB, Ingerman CM, Silver MJ. Malondialdehyde formation as an indicator of prostaglandin production by human platelets. J Lab Clin Med 1976; 88 (I) 162-172
• 14 Forconi S, Guerrini M, Pieragalli D, Acciavatti A. Viscosimetria ematica – approccio metodologico. Ric Clin Lab 1981; 11 (Suppl. 01) 135 149
• 15 Crepaldi G, Muggero M, Calabro A, Lapolla A. Alterazioni emoreologiche in alcune sindromi metaboliche. Ric Clin Lab 1981; 11 (Suppl. 01) 59-71
• 16 Vettore L. Basi biochimiche della deformabilità eritrocitaria. Ric Clin Lab 1981; 11 (Suppl. 01) 89-98
• 17 Bills TK, Smith JB, Silver MJ. Platelet uptake, release and oxidation of ¹⁴C-arachidonic acid. In: Prostaglandins in Hematology. Silver MJ, Smith JB, Kocsis JJ. (eds). pp. 27-55 Spectrum Publications; New York: 1977
• 18 Granstràm E. Metabolism of prostaglandins. In: Prostaglandins and thromboxanes. Berti F, Samuelsson B, Velo GP. (eds). pp. 75-83 Plenum Press; New York: 1976
• 19 Samuelsson B, Hamberg M, Malmsten C, Svensson J. The role of prostaglandin endoperoxides and thromboxanes in platelet aggregation. In: Advances in Prostaglandin and Thromboxane Research (II). Samuelsson B, Paoletti R. (eds). pp. 737-764 Raven Press; New York: 1976
• 20 Dormandy JA, Ernst E, Bennett D. Erythrocyte deformability in the pathophysiology of the microcirculation. Ric Clin Lab 1981; 11 (Suppl. 01) 35-38
• 21 Dusting GJ, Moncada S, Vane JR. Prostacyclin (PGX) is the endogenous metabolite responsible for relaxation of coronary arteries induced by arachidonic acid. Prostaglandins 1977; 13: 3-15
• 22 Moncada S, Herman AG, Higgs EA, Vane JR. Differential formation of prostacyclin (PGX or PGI₂) by layer of the arterial wall. An explanation for the antithrombotic properties of vascular endothelium. Thromb Res 1977; 11: 323-344